Perspectives on Oncolytic Salmonella in Cancer Immunotherapy—A Promising Strategy
Since the first reported spontaneous regression of tumors in patients with streptococcus infection, cancer biological therapy was born and it evolved into today’s immunotherapy over the last century. Although the original strategy was unable to impart maximal therapeutic benefit at the beginning, it...
Main Authors: | Ding Wang, Xiaodong Wei, Dhan V. Kalvakolanu, Baofeng Guo, Ling Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.615930/full |
Similar Items
-
Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
by: Yalei Zhang, et al.
Published: (2021-05-01) -
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)
by: Paolo A. Ascierto, et al.
Published: (2019-11-01) -
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy)
by: Paolo A. Ascierto, et al.
Published: (2021-06-01) -
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge” (December 4th–5th, 2019, Naples, Italy)
by: Paolo A. Ascierto, et al.
Published: (2021-01-01) -
Perspectives on immunotherapy via oncolytic viruses
by: Alberto Reale, et al.
Published: (2019-02-01)